Procalcitonin as an effective biomarker for the diagnosis and prognosis of severe sepsis. Highlights from the 25th International Symposium on Intensive Care and Emergency Medicine. March 21-25, 2005, Brussels, Belgium.
Several reports presented at the 25th International Symposium on Intensive Care and Emergency Medicine held March 21-25 in Brussels, Belgium, have demonstrated the efficacy of using the prohormone procalcitonin (PCT) as a biomarker for severe sepsis. This article reviews some of the most exciting studies.
Sorbera
Lisa Ann
LA
Prous Science, Barcelona, Spain. journals@prous.com
D015415:Biomarkers / Q000097:blood; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D002986:Clinical Trials as Topic; D006801:Humans; D011379:Prognosis; D011498:Protein Precursors / Q000097:blood*; D018805:Sepsis / Q000175:diagnosis*; D012720:Severity of Illness Index
D015415:Biomarkers; C000606589:CALCA protein, human; D011498:Protein Precursors; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide